# An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)

> **NCT05411211** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 20 (actual)

## Conditions studied

- Polyarticular Juvenile Idiopathic Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05411211
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-10
- **Primary completion:** 2024-09-08
- **Final completion:** 2024-09-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05411211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05411211, "An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05411211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*